NEW YORK, June 12, 2019 /PRNewswire/ -- Global Meningococcal Vaccines Market: Overview
This report analyzes the current and future scenario of the global meningococcal vaccines market. Advancements in healthcare, increase in awareness and education through various non-profit organizations, and a rise in patient awareness and health care expenditure are key factors that are projected to drive the global market during the forecast period.

Read the full report: https://www.reportlinker.com/p03999775/?utm_source=PRN

The global meningococcal vaccines market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market.It also provides information and data analysis of the global market with respect to the segments based on type, end-user, and region.

A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section.Additionally, the section comprises a competitive matrix and company profiles along with business overview to understand the competitive landscape in the market.

This section of the report also provides market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global meningococcal vaccines market.

Global Meningococcal vaccines Market: Key Segments
The global meningococcal vaccines market has been segmented based on type, end-user, and region.In terms of type, the global market has been classified into polysaccharide vaccines, conjugate vaccines, combination vaccines, and Men B vaccines.

The polysaccharide vaccines segment has been further sub-segmented into Menomune, Mencevax, NmVac4, and others.The conjugate vaccines segment has been further sub-segmented into Menactra, Menveo, NeisVac-C, Nimenrix, Meningitec, Menjugate, MenAfriVac, and NmVac4-DT.

The combination vaccines segment has been further split into MenHibrix, and Menitorix.The Men B vaccines segment has been further sub-segmented into Bexsero, and Trumenba.

Based on end-user, the market has been classified into retail pharmacies, hospital pharmacies, and others. Based on region, the global market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these segments have been provided for the period from 2017 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Meningococcal vaccines Market: Regional Outlook
In terms of region, the global meningococcal vaccines market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, Israel, and rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2017 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in the Report
The report also profiles major players in the global meningococcal vaccines market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players profiled in the market report include Sanofi SA, Novartis International, GlaxoSmithKline plc, Pfizer Inc., Nuron Biotech, JN-International Medical Corporation, Serum Institute of India Ltd., Baxter International, and Biomed Pvt. Ltd.

The global meningococcal vaccines market has been segmented as below:

Global Meningococcal Vaccines Market, by Type
Polysaccharide Vaccines
Menomune
Mencevax
NmVac4
Others

Conjugate Vaccines
Menactra
Menveo
NeisVac-C
Nimenrix
Meningitec
Menjugate
MenAfriVac
NmVac4-DT
Combination Vaccines
MenHibrix
Menitorix
Men B Vaccines
Bexsero
Trumenba

Global Meningococcal Vaccines Market, by End-user
Retail Pharmacies
Hospital Pharmacies
Others

Global Meningococcal Vaccines Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa

Read the full report: https://www.reportlinker.com/p03999775/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/meningococcal-vaccines-market---global-industry-analysis-size-share-growth-trends-and-forecast-2018---2026-300866831.html

SOURCE Reportlinker